Keywords: CCI, chronic constriction injury; MOR, morphine; AMT, amitriptyline; DOX, doxepin; VFX, venlafaxine; ipl, intraplantar; sc, subcutaneousDoxepin; Venlafaxine; Amitriptyline; Neuropathic pain; Morphine
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC–MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxo
Keywords: DAM, Heroin, diamorphine; 6OM, 6-monoacetylmorphine; MOR, Morphine; M3G, Morphine-3-glucuronide; M6G, Morphine-6-glucuronide; NAL, Naloxone; NALT, NaltrexoneHeroin; LC–MS/MS; Plasma; Validation; Pharmacokinetic
Maternal hair testing for the assessment of fetal exposure to drug of abuse during early pregnancy: Comparison with testing in placental and fetal remains
Keywords: CYP450, cytochrome P450; MAM, 6-monoacetylmorphine; MOR, morphine; COC, cocaine; BEG, benzoylecgonine; MDMA, 3,4-methylenedioxymethamphetamine; MA, methamphetamine; THC, delta-9-tetrahydrocannabinol; THCCOOH, 11-nor-D9-tetrahydrocannabinol-9-carboxylic ac
The role of mu-opioid receptor signaling in the dorsolateral periaqueductal gray on conditional and unconditional responding to threatening and aversive stimuli
Keywords: CS, conditional stimulus; dlPAG, dorsolateral PAG; MOR, morphine; NAL, naltrexone; NAL1x, low dosage of NAL; NAL10x, high dosage of NAL; PAG, periaqueductal gray; US, unconditional stimulus; VEH, vehicle.opioids; periaqueductal gray; morphine; naltrexone;
The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs)
Keywords: PBMCs, peripheral blood mononuclear cells; hBCM-7, human β-casomorphin-7; bBCM-7, bovine β-casomorphin-7; CXN-6, casoxin-6; CXN-D, casoxin-D; MOR, morphine; NLX, naloxone; IL, interleukin; IFN, interferonOpioid peptides; β-Casomorphin-7; μ-Opioid receptor
The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine
Keywords: PAT, processed Aconiti tuber; KOR, kappa opioid receptor; NMDA, N-methyl-d-aspartate; Mor, morphine; U50488H, trans-(±)-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidin)cyclohexyl)-benzeneacetamide methane sulfonate hydrate; MK-801, (−)-5-methyl-10,11-dihydro-5H-
Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects
Keywords: CPP, conditioned place preference; DA, dopamine; EIA, enzyme immunoassay; GDNF, glial cell line-derived neurotrophic factor; METH, methamphetamine; MOR, morphine; NAc, nucleus accumbens; TNF-α, tumor necrosis factor-α; TH, tyrosine hydroxylase; VTA, ventr
Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice
Keywords: CPP, conditioned place preference; GPCR, G-protein-coupled receptor morphine; mor, morphine; sal, saline; THC, delta9-tetrahydrocannabinol; veh, vehicleConditioned place preference; Y-maze; Locomotor activity; Morphine; Reward
Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli
Keywords: RVM, rostral ventromedial medulla; PGE2, prostaglandin E2; 5-HT, serotonin; NE, norepinephrine; NRM, nucleus raphe magnus; MOR, morphine; SSRI, selective serotonin reuptake inhibitorPain; Radiant heat; Rostral ventromedial medulla (RVM); Microdialysis; Se